Catabasis Pharmaceuticals, Inc. (CATB) Minute Stock Prediction

About:

Catabasis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. The company’s lead product candidate is QLS-215, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development for the treatment of hereditary angioedema, a rare, debilitating and potentially life-threatening disease. The company was incorporated in 2008 and is based in Boston, Massachusetts.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

20

Address:

Catabasis Pharmaceuticals, Inc. 100 High Street 28th Floor Boston MA 02110 United States

Website:

http://www.catabasis.com

Phone:

617-349-1971